FDA commissioner praises Eli Lilly Alzheimer's treatment results
May 03, 2023 at 18:56 PM EDT
Donanemab slowed the decline in memory, in thinking and in the ability to conduct daily activities by 35%, according to Lilly's data.
Photography by Christophe Tomatis